Neoadjuvant chemotherapy for pineal region tumors - Summary - MDSpire

Neoadjuvant chemotherapy for pineal region tumors

  • By

  • Christopher Troy

  • David G. Laird

  • Cameron Brimley

  • Soniya Pinto

  • Sean Himel

  • Carlos Osorno-Cruz

  • Mustafa Motiwala

  • Emal Lesha

  • Kelly Chamberlin

  • Giles Robinson

  • Amar Gajjar

  • Jason Chiang

  • Nir Shimony

  • David S. Hersh

  • Paul Klimo

  • June 3, 2026

  • 0 min

Share

Objective:

To present the experience with neoadjuvant chemotherapy prior to definitive resection of pineal region tumors in a predominantly pediatric population, highlighting its potential impact on surgical outcomes.

Key Findings:
  • Neoadjuvant chemotherapy can reduce tumor vascularity, induce necrosis, and decrease overall tumor volume, with specific percentage reductions noted.
  • Gross total resection (GTR) is correlated with improved survival in certain tumor types, supported by statistical data.
  • Multidisciplinary treatment strategies are essential due to the complexity of pineal region tumors, with examples of successful collaborations.
Interpretation:

Neoadjuvant chemotherapy may improve surgical outcomes by making tumors more amenable to resection.

Limitations:
  • The study is retrospective and may have selection bias, which could affect the generalizability of the findings.
  • Germ cell tumors were excluded, limiting the generalizability of findings; further research is needed to explore their treatment.
Conclusion:

Neoadjuvant chemotherapy shows promise in managing pineal region tumors, warranting further investigation to validate these findings and explore implications for clinical practice.

Sources:

Original Source(s)

Related Content